Citadel Advisors
CPXX

Citadel Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Citadel Advisors’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-17,200
Closed -$519K – 8257
2016
Q2 		$519K Buy
17,200
+600
+4% +$12.2K ﹤0.01% 4433
2016
Q1 		$183K Buy
+16,600
New +$54.4K ﹤0.01% 5697

Citadel Advisors's CPXX Position: Q3 2016 in Review

Citadel Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 25,716 shares — an estimated $776K sold.

Citadel Advisors first reported a position in CPXX in Q1 2016 and held it in 2 quarters. The position peaked at $776K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Citadel Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Citadel Advisors sold 25,716 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $776K.
  • Citadel Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2016 and held it in 2 quarters.
  • Citadel Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $776K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Citadel Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.